Busca un médico

M Mateo Paz Soldan, M.D., Ph.D.

  1. Neurologist

Publicaciones

  1. Hoshina Y, Liu S, Wright MA, Delic A, Wong KH, Kadish R, Galli J, Rose JW, Greenlee JE, Soldán MMP, Klein J, Peterson LK, Smith TL, Clardy SL. Prolonged corticosteroid therapy and steroid-sparing maintenance immunotherapy lower relapse risk in pediatric and adult MOGAD. J Neuroimmunol. 2025 Oct 15; 407:578709. Epub 2025 Jul 30.
    View PubMed
  2. Hoshina Y, Abbatemarco JR, Rodenbeck SJ, Poon JT, Liu SC, Paz Soldan MM, Greenlee JE, Rose JW, Peterson LK, Johnson L, Delic A, Smith TL, Clardy SL. Matched oligoclonal bands: Diagnostic utility and clinical characteristics. Ann Clin Transl Neurol. 2024 Nov; 11(11):2846-2854. Epub 2024 Oct 22.
    View PubMed
  3. Mustafa R, Flanagan EP, Duffy DJ, Weinshenker BG, Soldán MMP, Kunchok A, Kaisey M, Solomon AJ. Laboratory evaluation for the differential diagnosis of possible multiple sclerosis in the United States: A physician survey. J Neurol Sci. 2023 Oct 15; 453:120781. Epub 2023 Sep 01.
    View PubMed
  4. De Almeida BI, Smith TL, Delic A, Esquibel L, Galli J, Millsap L, Paz Soldán MM, Cortez MM, Rose J, Greenlee JE, Gundlapalli AV, Hill HR, Wong KH, Clardy SL. Neurologic Manifestations of Common Variable Immunodeficiency: Impact on Quality of Life. Neurol Neuroimmunol Neuroinflamm. 2023 May; 10(3). Epub 2023 Feb 16.
    View PubMed
  5. Spain RI, Hildebrand A, Waslo CS, Rooney WD, Emmons J, Schwartz DL, Freedman MS, Paz Soldan MM, Repovic P, Solomon AJ, Rinker J 2nd, Wallin M, Haselkorn JK, Stuve O, Gross RH, Turner AP. Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosis. Front Neurol. 2023; 14:1188124. Epub 2023 Jun 08.
    View PubMed
  6. Hoshina Y, Galli J, Wong KH, Kovacsovics T, Steinbach M, Salzman KL, McNally JS, Lancaster E, Paz Soldán MM, Clardy SL. GABA-A Receptor Encephalitis After Autologous Hematopoietic Stem Cell Transplant forMultiple Myeloma: Three Cases and Literature Review. Neurol Neuroimmunol Neuroinflamm. 2022 Nov; 9(6). Epub 2022 Aug 26.
    View PubMed
  7. Poon JT, Salzman K, Clardy SL, Paz Soldan MM. Adrenal Crisis Presenting as Recurrent Encephalopathy Mimicking Autoimmune, Infectious Encephalitis, and Common Variable Immune Deficiency: A Case Report. Neurologist. 2022 Jul 01; 27(4):206-210.
    View PubMed
  8. Abbatemarco JR, Galli JR, Sweeney ML, Carlson NG, Samara VC, Davis H, Rodenbeck S, Wong KH, Paz Soldan MM, Greenlee JE, Rose JW, Delic A, Clardy SL. Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population. Neurol Neuroimmunol Neuroinflamm. 2021 Nov; 8(6). Epub 2021 Aug 31.
    View PubMed
  9. Villani LA, Stulberg EL, Abbatemarco JR, Davidson CJ, Kadish R, Renner DR, Soldan MMP, Rose JW, Clardy SL, Greenlee JE. Biopsy-proven PML in an HIV-negative patient with discoid lupus: Failure to detect JC virus in CSF. Clin Neurol Neurosurg. 2021 Oct; 209:106843. Epub 2021 Jul 27.
    View PubMed
  10. Kassa RM, Sechi E, Flanagan EP, Kaufmann TJ, Kantarci OH, Weinshenker BG, Mandrekar J, Schmalstieg WF, Paz Soldan MM, Keegan BM. Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions. Mult Scler. 2021 May; 27(6):895-902. Epub 2020 Jul 15.
    View PubMed
  11. Williams JP, Abbatemarco JR, Galli JJ, Rodenbeck SJ, Peterson LK, Haven TR, Street M, Rose JW, Greenlee JE, Soldan MMP, Clardy SL. Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay. Mult Scler Int. 2021; 2021:8692328. Epub 2021 Sep 28.
    View PubMed
  12. Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L, ASCLEPIOS I and ASCLEPIOS II Trial Groups. Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med. 2020 Aug 06; 383(6):546-557.
    View PubMed
  13. Lord J, Paz Soldan MM, Galli J, Salzman KL, Kresser J, Bacharach R, DeWitt LD, Klein J, Rose J, Greenlee J, Clardy SL. Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system. Neurol Neuroimmunol Neuroinflamm. 2020 Jul; 7(4). Epub 2020 May 13.
    View PubMed
  14. Hollen CW, Paz Soldán MM, Rinker JR 2nd, Spain RI. The Future of Progressive Multiple Sclerosis Therapies. Fed Pract. 2020 Apr; 37(Suppl 1):S43-S49.
    View PubMed
  15. Piquet AL, Khan M, Warner JEA, Wicklund MP, Bennett JL, Leehey MA, Seeberger L, Schreiner TL, Paz Soldan MM, Clardy SL. Novel clinical features of glycine receptor antibody syndrome: A series of 17 cases. Neurol Neuroimmunol Neuroinflamm. 2019 Sep; 6(5):e592. Epub 2019 Jul 01.
    View PubMed
  16. Toledano M, Weinshenker BG, Kaufmann TJ, Parisi JE, Paz Soldan MM. Demographics and clinical characteristics of episodic hypothermia in multiple sclerosis. Mult Scler. 2019 Apr; 25 (5):709-714 Epub 2018 Mar 23
    View PubMed
  17. Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP. Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease. Mult Scler. 2018 Oct; 24 (11):1445-1452 Epub 2018 July 26
    View PubMed
  18. Sweeney M, Sweney M, Soldán MM, Clardy SL. Antineuronal Nuclear Autoantibody Type 1/Anti-Hu-Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua: Case Report and Literature Review. Pediatr Neurol. 2016 Dec; 65:86-89. Epub 2016 Sep 02.
    View PubMed
  19. Galli JR, Clardy SL, Paz Soldán MM. Adult-onset Opsoclonus-Myoclonus Syndrome Associated With Ganglionic Acetylcholine Receptor Autoantibody. Neurologist. 2016 Nov; 21(6):99-100.
    View PubMed
  20. Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP. Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion. Neurology. 2016 Oct 18; 87 (16):1713-1719 Epub 2016 Sept 16
    View PubMed
  21. Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, Weinshenker BG, Rodriguez M, Kantarci OH, Nelson H, Murray JA, Mangalam AK. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016 Jun 27; 6:28484 Epub 2016 June 27
    View PubMed
  22. Novotna M, Paz Soldan MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH. Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology. 2015 Aug 25; 85 (8):722-9 Epub 2015 July 24
    View PubMed
  23. Paz Soldan MM, Raman MR, Gamez JD, Lohrey AK, Chen Y, Pirko I, Johnson AJ. Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis. J Neuroimaging. 2015 Jul-Aug; 25 (4):595-9 Epub 2015 Apr 20
    View PubMed
  24. Paz Soldan MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH. Relapses and disability accumulation in progressive multiple sclerosis. Neurology. 2015 Jan 6; 84 (1):81-8 Epub 2014 Nov 14
    View PubMed
  25. Moseley BD, Smith JH, Diaz-Medina GE, Paz Soldan MM, Wicklund M, Dhamija R, Reda H, Presti MF, Britton JW. Standardized sign-out improves completeness and perceived accuracy of inpatient neurology handoffs. Neurology. 2012 Sep 04; 79(10):1060-4. Epub 2012 Aug 08.
    View PubMed
  26. Paz Soldan MM, Pittock SJ, Weigand SD, Yawn BP, Rodriguez M. Statin therapy and multiple sclerosis disability in a population-based cohort. Mult Scler. 2012 Mar; 18 (3):358-63 Epub 2011 Sept 09
    View PubMed
  27. Paz Soldan MM, Pirko I. Biogenesis and significance of central nervous system myelin. Semin Neurol. 2012 Feb; 32(1):9-14. Epub 2012 Mar 15
    View PubMed
  28. Ciric B, Van Keulen V, Paz Soldan M, Paz Soldan M, Rodriguez M, Pease LR. Antibody-mediated remyelination operates through mechanism independent of immunomodulation. J Neuroimmunol. 2004 Jan; 146 (1-2):153-61
    View PubMed
  29. Joyce JN, Presgraves S, Renish L, Borwege S, Osredkar T, Hagner D, Replogle M, Paz Soldan M, Millan MJ. Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole. Exp Neurol. 2003 Nov; 184(1):393-407.
    View PubMed
  30. Ciric B, Howe CL, Paz Soldan M, Warrington AE, Bieber AJ, Van Keulen V, Rodriguez M, Pease LR. Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol. 2003 Oct; 13 (4):608-16
    View PubMed
  31. Paz Soldan MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Rodriguez M. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci. 2003 Jan; 22 (1):14-24
    View PubMed
  32. Paz Soldan MM, Rodriguez M. Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination. J Infect Dis. 2002 Dec 1; 186 Suppl 2:S248-53.
    View PubMed
  33. Mitsunaga Y, Ciric B, Van Keulen V, Warrington AE, Paz Soldan M, Bieber AJ, Rodriguez M, Pease LR. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J. 2002 Aug; 16 (10):1325-7 Epub 2002 June 21
    View PubMed
  34. Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Mitsunaga Y, Paz Soldan MM, Rodriguez M, Rodriguez M. Immunoglobulin-mediated CNS repair. J Allergy Clin Immunol. 2001 Oct; 108 (4 Suppl):S121-5
    View PubMed
PST-20572046